Tracleer is a Oral Tablet, Soluble in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Bosentan.
| Product ID | 66215-232_9fd08026-228f-4cd1-aefe-3a2802958bc6 |
| NDC | 66215-232 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tracleer |
| Generic Name | Bosentan |
| Dosage Form | Tablet, Soluble |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-07-29 |
| Marketing Category | NDA / |
| Application Number | NDA209279 |
| Labeler Name | Actelion Pharmaceuticals US, Inc. |
| Substance Name | BOSENTAN |
| Active Ingredient Strength | 32 mg/1 |
| Pharm Classes | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-07-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66215-101 | Tracleer | bosentan |
| 66215-102 | Tracleer | Tracleer |
| 66215-103 | Tracleer | Tracleer |
| 0054-0520 | Bosentan | Bosentan |
| 0054-0521 | Bosentan | Bosentan |
| 0591-2511 | bosentan | bosentan |
| 0591-2512 | bosentan | bosentan |
| 10148-125 | bosentan | bosentan |
| 10148-625 | bosentan | bosentan |
| 46708-383 | Bosentan | Bosentan |
| 46708-384 | Bosentan | Bosentan |
| 47335-038 | Bosentan | Bosentan |
| 47335-039 | Bosentan | Bosentan |
| 47781-270 | Bosentan | Bosentan |
| 47781-271 | Bosentan | Bosentan |
| 49884-058 | Bosentan | Bosentan |
| 49884-059 | Bosentan | Bosentan |
| 62332-383 | Bosentan | Bosentan |
| 62332-384 | Bosentan | Bosentan |
| 65162-873 | Bosentan | Bosentan |
| 65162-874 | Bosentan | Bosentan |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRACLEER 76177722 2648305 Live/Registered |
Actelion Pharmaceuticals Ltd. 2000-12-07 |